Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 serious adverse event: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 5: | Line 5: | ||
serious adverse event | serious adverse event | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00046-Ser-sSc ++ TAG-00004-Ser-ege ++ TAG-00047-Une-ete ++ TAG-00244-Def-ini ++ TAG-00258-Ser-nfü | ||
| | |RefModule=5 | ||
| | |RefUnit=5.1.1 | ||
}} | }} | ||
| Line 15: | Line 15: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 5 — Unit 5.1.1 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 32: | Line 35: | ||
| | | | ||
|- | |- | ||
! Tags | ! Tags | ||
| | | [[Glossary:TAG-00046-Ser-sSc|Serious adverse event]], [[Glossary:TAG-00004-Ser-ege|Serious adverse reaction]], [[Glossary:TAG-00047-Une-ete|Unexpected SAR]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00258-Ser-nfü|Seriousness criteria]] | ||
|- | |||
| | |||
|- | |||
| | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 5 — Unit 5.1.1 |
| Scope | HM |
| Document part | Article 2
serious adverse event |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Serious adverse event, Serious adverse reaction, Unexpected SAR, Definition, Seriousness criteria |
| Comment | Definitions of SAE, SAR and USAR (UK) |
Content
“serious adverse event”, “serious adverse reaction” or “unexpected serious adverse reaction” means any adverse event, adverse reaction or unexpected adverse reaction, respectively, that— (a)results in death, (b)is life-threatening, (c)requires hospitalisation or prolongation of existing hospitalisation, (d)results in persistent or significant disability or incapacity, or (e)consists of a congenital anomaly or birth defect;
